These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 32211216)

  • 61. Advances in microscopy and complementary imaging techniques to assess the fate of drugs ex vivo in respiratory drug delivery: an invited paper.
    Park CW; Rhee YS; Vogt FG; Hayes D; Zwischenberger JB; DeLuca PP; Mansour HM
    Adv Drug Deliv Rev; 2012 Mar; 64(4):344-56. PubMed ID: 21920394
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Olfactory targeting through intranasal delivery of biopharmaceutical drugs to the brain: current development.
    Wen MM
    Discov Med; 2011 Jun; 11(61):497-503. PubMed ID: 21712015
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nose-to-Brain Delivery of Therapeutic Peptides as Nasal Aerosols.
    Alabsi W; Eedara BB; Encinas-Basurto D; Polt R; Mansour HM
    Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145618
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials.
    Bruinsmann FA; Richter Vaz G; de Cristo Soares Alves A; Aguirre T; Raffin Pohlmann A; Stanisçuaski Guterres S; Sonvico F
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31779126
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Numerical Comparison of Nasal Aerosol Administration Systems for Efficient Nose-to-Brain Drug Delivery.
    Dong J; Shang Y; Inthavong K; Chan HK; Tu J
    Pharm Res; 2017 Dec; 35(1):5. PubMed ID: 29288465
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
    Horger M; Bares R
    Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Demonstration of Direct Nose-to-Brain Transport of Unbound HIV-1 Replication Inhibitor DB213 Via Intranasal Administration by Pharmacokinetic Modeling.
    Wang Q; Zhang Y; Wong CH; Edwin Chan HY; Zuo Z
    AAPS J; 2017 Dec; 20(1):23. PubMed ID: 29282567
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Imaging techniques for assessing drug delivery in man.
    Newman SP; Wilding IR
    Pharm Sci Technol Today; 1999 May; 2(5):181-189. PubMed ID: 10322380
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview.
    Djupesland PG; Messina JC; Mahmoud RA
    Ther Deliv; 2014 Jun; 5(6):709-33. PubMed ID: 25090283
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intranasal treatment of neurodegenerative diseases and stroke.
    Gomez D; Martinez JA; Hanson LR; Frey WH; Toth CC
    Front Biosci (Schol Ed); 2012 Jan; 4(1):74-89. PubMed ID: 22202044
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles.
    Kanazawa T; Akiyama F; Kakizaki S; Takashima Y; Seta Y
    Biomaterials; 2013 Dec; 34(36):9220-6. PubMed ID: 23992922
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A brief review of reporter gene imaging in oncolytic virotherapy and gene therapy.
    Concilio SC; Russell SJ; Peng KW
    Mol Ther Oncolytics; 2021 Jun; 21():98-109. PubMed ID: 33981826
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Exploring Nose to Brain Nano Delivery for Effective Management of Migraine.
    Tanna V; Sawarkar SP; Ravikumar P
    Curr Drug Deliv; 2023; 20(2):144-157. PubMed ID: 35366772
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Nose-to-Brain Delivery.
    Wang Z; Xiong G; Tsang WC; Schätzlein AG; Uchegbu IF
    J Pharmacol Exp Ther; 2019 Sep; 370(3):593-601. PubMed ID: 31126978
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Novel vasoconstrictor formulation to enhance intranasal targeting of neuropeptide therapeutics to the central nervous system.
    Dhuria SV; Hanson LR; Frey WH
    J Pharmacol Exp Ther; 2009 Jan; 328(1):312-20. PubMed ID: 18945930
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Direct transport of VEGF from the nasal cavity to brain.
    Yang JP; Liu HJ; Cheng SM; Wang ZL; Cheng X; Yu HX; Liu XF
    Neurosci Lett; 2009 Jan; 449(2):108-11. PubMed ID: 18996442
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Design and Application in Delivery System of Intranasal Antidepressants.
    Xu J; Tao J; Wang J
    Front Bioeng Biotechnol; 2020; 8():626882. PubMed ID: 33409272
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nanomedicine for Intranasal Delivery to Improve Brain Uptake.
    Patel AA; Patel RJ; Patel SR
    Curr Drug Deliv; 2018; 15(4):461-469. PubMed ID: 29034836
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration.
    Lochhead JJ; Wolak DJ; Pizzo ME; Thorne RG
    J Cereb Blood Flow Metab; 2015 Mar; 35(3):371-81. PubMed ID: 25492117
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Imaging tests for the detection of osteomyelitis: a systematic review.
    Llewellyn A; Jones-Diette J; Kraft J; Holton C; Harden M; Simmonds M
    Health Technol Assess; 2019 Oct; 23(61):1-128. PubMed ID: 31670644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.